Opportunities Preloader

Please Wait.....

Report

NLP in Healthcare & Life Sciences - Company Evaluation Report, 2025

Market Report I 2025-08-01 I 153 Pages I MarketsandMarkets

The NLP in Healthcare & Life Sciences Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for NLP in Healthcare & Life Sciences. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 33 NLP in Healthcare & Life Sciences Companies were categorized and recognized as quadrant leaders.
Driven by the surge in unstructured medical data and the growing need for actionable insights, Natural Language Processing (NLP) technologies are increasingly being adopted to analyze clinical notes, patient records, scientific publications, and voice data. These solutions enhance healthcare outcomes by improving the speed, accuracy, and efficiency of information retrieval and decision-making. The market is poised for strong growth between 2025 and 2030, fueled by continued digital transformation, evolving healthcare delivery models, and the increasing demand for intelligent automation in clinical and operational workflows.
This report delivers an in-depth analysis of the NLP in the healthcare market, with a primary focus on software and platform solutions, while excluding services due to their relatively limited direct contribution to market value. The market is segmented by NLP techniques, applications, end users, deployment models, and geographic regions. By evaluating the role of each segment, the report offers strategic insights into competitive dynamics, key trends, and growth opportunities, equipping stakeholders with the information necessary to navigate and capitalize on developments in this rapidly advancing domain.
The 360 Quadrant maps the NLP in Healthcare & Life Sciences companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the NLP in Healthcare & Life Sciences quadrant. The top criteria for product footprint evaluation included By OFFERING (Software, Services), By DEPLOYMENT MODE (Cloud, On-premises), By NLP TYPE (Natural Language Understanding, Natural Language Generation), By NLP TECHNIQUE (Optical Character Recognition, Named Entity Recognition, Sentiment Analysis, Text Classification, Topic Modeling, Text Summarization, Other NLP Techniques), By APPLICATION (Patient Care & Engagement, Clinical Operations & Decision Support, Biomedical Research & Drug Development, Administrative & Operations Management, Genomics & Precision Medicine, Medical Education & Knowledge Dissemination, Other Applications), and By END USER (Clinical Practitioners, Healthcare Researchers, Healthcare Administrators, Health Insurance & Payer Professionals, Pharmaceutical & Biotech Companies, Other End Users).

Key Players
Key players in the NLP in Healthcare & Life Sciences market include major global corporations and specialized innovators such as Ibm, Microsoft, Google, Aws, Iqvia, Oracle, Inovalon, Dolbey Systems, Averbis, Sas Institute, Solventum, Press Ganey, Ellipsis Health, Lexalytics, Nvidia, Ge Healthcare, Clinithink, Hpe, Oncora Medical, Flatiron Health, Datavant, Edifecs, John Snow Labs, Itrex Group, Kms Healthcare, Appinventiv, Reveal Healthtech, Veritis, Optum, Health Catalyst, Amboss, Maruti Techlabs, and Deepscribe. These companies are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.


Top 3 Companies

Google
Google holds a significant position in the market by leveraging its deep AI capabilities and cloud infrastructure. The company offers scalable NLP solutions through Google Cloud, including products like AutoML and Vertex AI. These tools empower healthcare providers to extract insights from unstructured data, driving advancements in diagnostics and treatment personalization. Google's commitment to responsible AI, data security, and strategic global partnerships further consolidates its market leadership.

IQVIA
IQVIA excels in utilizing its vast repository of real-world healthcare data to enhance clinical trial efficiency and pharmacovigilance. The company deploys proprietary NLP engines to mine structured insights from various data forms, supporting drug discovery and commercial strategies. IQVIA's integrated analytics and extensive data assets position it as a pivotal player in transforming healthcare data into actionable intelligence.

Microsoft
Microsoft enhances its market presence through Azure Health Data Services, integrating NLP for efficient data processing and interoperability. By offering tools compliant with FHIR and embedded AI models, it supports healthcare workflows and clinical decision-making processes. Microsoft's strategy of leveraging AI technologies and strong industry partnerships cements its role in advancing the healthcare NLP landscape.

1 INTRODUCTION 12
1.1 MARKET DEFINITION 12
1.2 INCLUSIONS AND EXCLUSIONS 12
1.3 STAKEHOLDERS 14
2 EXECUTIVE SUMMARY 15
3 MARKET OVERVIEW 21
3.1 INTRODUCTION 21
3.2 MARKET DYNAMICS 22
3.2.1 DRIVERS 22
3.2.1.1 Surging volume of unstructured clinical data 22
3.2.1.2 Rising demand for enhanced care delivery and patient engagement 23
3.2.1.3 Need for predictive analytics to improve significant health concerns 23
3.2.1.4 Increasing focus on enhancing clinical decision support 24
3.2.2 RESTRAINTS 24
3.2.2.1 Clinical accuracy and reliability concerns 24
3.2.2.2 Issues related to domain-specific language and medical terminology in NLP model development 24
3.2.2.3 Complexity in integrating NLP with established healthcare system 25
3.2.3 OPPORTUNITIES 25
3.2.3.1 Rising adoption of computer-assisted coding to enhance productivity 25
3.2.3.2 Emergence of advanced AI technology for generating valuable insights for healthcare 25
3.2.3.3 Emergence of cognitive computing for medicine applications 26
3.2.4 CHALLENGES 26
3.2.4.1 Model training data limitations 26
3.2.4.2 High cost of implementation and maintenance of NLP technology 26
3.2.4.3 Explainability and interpretability issues while deploying NLP algorithms 27
3.3 IMPACT OF 2025 US TARIFF-NLP IN HEALTHCARE & LIFE SCIENCES MARKET 27
3.3.1 INTRODUCTION 27
3.3.2 KEY TARIFF RATES 28
3.3.3 PRICE IMPACT ANALYSIS 28
3.3.3.1 Strategic shifts and emerging trends 28
3.3.4 IMPACT ON COUNTRY/REGION 29
3.3.4.1 US 29
3.3.4.1.1 Strategic shifts and key observations 29
3.3.4.2 China 30
3.3.4.2.1 Strategic shifts and key observations 31
3.3.4.3 Europe 31
3.3.4.3.1 Strategic shifts and key observations 32
3.3.4.4 India 32
3.3.4.4.1 Strategic shifts and key observations 33
3.3.5 IMPACT ON END-USE INDUSTRIES 33
3.3.5.1 Clinical practitioners 33
3.3.5.2 Healthcare Researchers 34
3.3.5.3 Pharmaceutical & Biotech companies 34
3.4 EVOLUTION OF NLP IN HEALTHCARE & LIFE SCIENCES MARKET 34
3.5 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: ARCHITECTURE 35
3.6 SUPPLY CHAIN ANALYSIS 36
3.7 ECOSYSTEM ANALYSIS 37
3.7.1 SOFTWARE & SERVICE PROVIDERS BY APPLICATION 40
3.7.1.1 Patient care & engagement 40
3.7.1.2 Clinical operations & decision support 40
3.7.1.3 Biomedical research & drug development 40
3.7.1.4 Administrative & operations management 40
3.7.1.5 Genomics & precision medicine 40
3.7.1.6 Medical education & knowledge dissemination 41
3.8 TECHNOLOGY ANALYSIS 41
3.8.1 KEY TECHNOLOGIES 41
3.8.1.1 Generative AI 41
3.8.1.2 Natural Language Processing (NLP) 41
3.8.1.3 Machine Learning 42
3.8.1.4 Computer Vision 42
3.8.2 COMPLIMENTARY TECHNOLOGIES 42
3.8.2.1 Conversational AI 42
3.8.2.2 Emotion AI 43
3.8.2.3 Cloud computing 43
3.8.3 ADJACENT TECHNOLOGIES 43
3.8.3.1 Edge AI 43
3.8.3.2 Blockchain 44
3.8.3.3 AR/VR 44
3.9 PATENT ANALYSIS 44
3.9.1 METHODOLOGY 44
3.9.2 PATENTS FILED, BY DOCUMENT TYPE 45
3.9.3 INNOVATION AND PATENT APPLICATIONS 45
3.10 KEY CONFERENCES AND EVENTS, 2025-2026 49
3.11 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: BUSINESS MODELS 50
3.11.1 SAAS MODEL 50
3.11.2 CONSULTING SERVICES MODEL 50
3.11.3 REVENUE SHARING MODEL 50
3.11.4 PAY-PER-USE MODEL 50
3.12 PORTER'S FIVE FORCES ANALYSIS 50
3.12.1 THREAT OF NEW ENTRANTS 52
3.12.2 THREAT OF SUBSTITUTES 52
3.12.3 BARGAINING POWER OF SUPPLIERS 52
3.12.4 BARGAINING POWER OF BUYERS 52
3.12.5 INTENSITY OF COMPETITIVE RIVALRY 53
3.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 53
4 COMPETITIVE LANDSCAPE 54
4.1 OVERVIEW 54
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025 54
4.3 REVENUE ANALYSIS, 2020-2024 57
4.4 MARKET SHARE ANALYSIS, 2024 57
4.5 PRODUCT COMPARATIVE ANALYSIS 60
4.5.1 PRODUCT COMPARATIVE ANALYSIS, BY OFFERING 60
4.5.1.1 Health Discovery (Averbis) 60
4.5.1.2 Fusion CDI (Dolbey Systems) 61
4.5.1.3 Clinical Documentation Integrity (Solventum) 61
4.5.1.4 Cloud Healthcare API (Google) 61
4.5.1.5 Inovalon ONE platform (Inovalon) 61
4.5.2 PRODUCT COMPARATIVE ANALYSIS, BY APPLICATION 62
4.5.2.1 IBM Watsonx Assistant (IBM) 62
4.5.2.2 Microsoft Dragon CoPilot (Microsoft) 63
4.5.2.3 Oracle Clinical Digital Assistant (Oracle) 63
4.5.2.4 IQVIA NLP Risk Adjustment (IQVIA) 63
4.5.2.5 AWS HealthLake (AWS) 63
4.6 COMPANY VALUATION AND FINANCIAL METRICS 63
4.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 64
4.7.1 STARS 65
4.7.2 EMERGING LEADERS 65
4.7.3 PERVASIVE PLAYERS 65
4.7.4 PARTICIPANTS 65
4.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 67
4.7.5.1 Company footprint 67
4.7.5.2 Regional footprint 67
4.7.5.3 Offering footprint 68
4.7.5.4 Application footprint 69
4.7.5.5 End user footprint 70
4.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 71
4.8.1 PROGRESSIVE COMPANIES 71
4.8.2 RESPONSIVE COMPANIES 71
4.8.3 DYNAMIC COMPANIES 71
4.8.4 STARTING BLOCKS 71
4.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 73
4.8.5.1 Detailed list of key startups/SMEs 73
4.8.5.2 Competitive benchmarking of key startups/SMEs 74
4.9 COMPETITIVE SCENARIO AND TRENDS 75
4.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS 75
4.9.2 DEALS 76
5 COMPANY PROFILES 79
5.1 INTRODUCTION 79
5.2 KEY PLAYERS 79
5.2.1 IBM 79
5.2.1.1 Business overview 79
5.2.1.2 Products/Solutions/Services offered 80
5.2.1.3 Recent developments 81
5.2.1.4 MnM view 82
5.2.1.4.1 Right to win 82
5.2.1.4.2 Strategic choices 82
5.2.1.4.3 Weaknesses and competitive threats 82
5.2.2 MICROSOFT 83
5.2.2.1 Business overview 83
5.2.2.2 Products/Solutions/Services offered 84
5.2.2.3 Recent developments 85
5.2.2.4 MnM view 87
5.2.2.4.1 Right to win 87
5.2.2.4.2 Strategic choices 88
5.2.2.4.3 Weaknesses and competitive threats 88
5.2.3 GOOGLE 89
5.2.3.1 Business overview 89
5.2.3.2 Products/Solutions/Services offered 90
5.2.3.3 Recent developments 91
5.2.3.4 MnM view 92
5.2.3.4.1 Right to win 92
5.2.3.4.2 Strategic choices 92
5.2.3.4.3 Weaknesses and competitive threats 93
5.2.4 AWS 94
5.2.4.1 Business overview 94
5.2.4.2 Products/Solutions/Services offered 95
5.2.4.3 Recent developments 95
5.2.4.4 MnM view 98
5.2.4.4.1 Right to win 98
5.2.4.4.2 Strategic choices 98
5.2.4.4.3 Weaknesses and competitive threats 98
5.2.5 IQVIA 99
5.2.5.1 Business overview 99
5.2.5.2 Products/Solutions/Services offered 100
5.2.5.3 Recent developments 101
5.2.5.4 MnM view 103
5.2.5.4.1 Right to win 103
5.2.5.4.2 Strategic choices 103
5.2.5.4.3 Weaknesses and competitive threats 103
5.2.6 ORACLE 104
5.2.6.1 Business overview 104
5.2.6.2 Products/Solutions/Services offered 105
5.2.6.3 Recent developments 106
5.2.7 INOVALON 108
5.2.7.1 Business overview 108
5.2.7.2 Products/Solutions/Services offered 108
5.2.7.3 Recent developments 109
5.2.8 DOLBEY SYSTEMS 111
5.2.8.1 Business overview 111
5.2.8.2 Products/Solutions/Services offered 111
5.2.8.3 Recent developments 112
5.2.9 AVERBIS 114
5.2.9.1 Business overview 114
5.2.9.2 Products/Solutions/Services offered 114
5.2.9.3 Recent developments 115
5.2.10 SAS INSTITUTE 116
5.2.10.1 Business overview 116
5.2.10.2 Products/Solutions/Services offered 116
5.2.10.3 Recent developments 117
5.2.11 SOLVENTUM 120
5.2.11.1 Business overview 120
5.2.11.2 Products/Solutions/Services offered 121
5.2.11.3 Recent developments 122
5.2.12 PRESS GANEY 123
5.2.13 ELLIPSIS HEALTH 123
5.2.14 LEXALYTICS 124
5.2.15 NVIDIA 125
5.2.16 GE HEALTHCARE 126
5.2.17 CLINITHINK 126
5.2.18 HPE 127
5.2.19 ONCORA MEDICAL 128
5.2.20 FLATIRON HEALTH 129
5.2.21 DATAVANT 130
5.2.22 EDIFECS 131
5.2.23 JOHN SNOW LABS 132
5.2.24 ITREX GROUP 132
5.2.25 KMS HEALTHCARE 133
5.2.26 APPINVENTIV 134
5.2.27 REVEAL HEALTHTECH 135
5.2.28 VERITIS 136
5.2.29 OPTUM 136
5.2.30 HEALTH CATALYST 137
5.2.31 AMBOSS 138
5.2.32 MARUTI TECHLABS 138
5.2.33 DEEPSCRIBE 139
5.3 OTHER PLAYERS 140
5.3.1 FORESEE MEDICAL 140
5.3.2 GNANI.AI 141
5.3.3 NOTABLE HEALTH 142
5.3.4 BIOFOURMIS 142
5.3.5 SUKI AI 143
5.3.6 WAVE HEALTH TECHNOLOGIES 144
5.3.7 CORTI 145
5.3.8 CLOUDMEDX 145
5.3.9 EMTELLIGENT 146
5.3.10 ENLITIC 147
5.3.11 DEEP 6 AI 148
6 APPENDIX 149
6.1 RESEARCH METHODOLOGY 149
6.1.1 RESEARCH DATA 149
6.1.1.1 Secondary data 150
6.1.1.2 Primary data 150
6.1.2 RESEARCH ASSUMPTIONS 151
6.1.3 RESEARCH LIMITATIONS 153
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 153

TABLE 1 GLOBAL NLP IN HEALTHCARE & LIFE SCIENCES MARKET SIZE AND GROWTH RATE, 2020-2024 (USD MILLION, Y-O-Y %) 17
TABLE 2 GLOBAL NLP IN HEALTHCARE & LIFE SCIENCES MARKET SIZE AND GROWTH RATE, 2025-2030 (USD MILLION, Y-O-Y %) 17
TABLE 3 US ADJUSTED RECIPROCAL TARIFF RATES 28
TABLE 4 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: ROLE OF PLAYERS IN ECOSYSTEM 37
TABLE 5 PATENTS FILED, 2016-2025 45
TABLE 6 LIST OF TOP PATENTS IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET,
2024-2025 46
TABLE 7 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
DETAILED LIST OF CONFERENCES AND EVENTS, 2025-2026 49
TABLE 8 PORTERS' FIVE FORCES' IMPACT ON NLP IN
HEALTHCARE & LIFE SCIENCES MARKET 51
TABLE 9 OVERVIEW OF STRATEGIES ADOPTED BY KEY NLP IN HEALTHCARE & LIFE SCIENCES VENDORS, 2022-2025 54
TABLE 10 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DEGREE OF COMPETITION 58
TABLE 11 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: REGIONAL FOOTPRINT 67
TABLE 12 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: OFFERING FOOTPRINT 68
TABLE 13 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: APPLICATION FOOTPRINT 69
TABLE 14 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: END USER FOOTPRINT 70
TABLE 15 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: KEY STARTUPS/SMES, 2024 73
TABLE 16 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 74
TABLE 17 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022-MAY 2025 75
TABLE 18 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
DEALS, JANUARY 2022-MAY 2025 76
TABLE 19 IBM: BUSINESS OVERVIEW 79
TABLE 20 IBM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 80
TABLE 21 IBM: PRODUCT LAUNCHES & ENHANCEMENTS 81
TABLE 22 IBM: DEALS 81
TABLE 23 MICROSOFT: BUSINESS OVERVIEW 83
TABLE 24 MICROSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 84
TABLE 25 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS 85
TABLE 26 MICROSOFT: DEALS 86
TABLE 27 GOOGLE: BUSINESS OVERVIEW 89
TABLE 28 GOOGLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 90
TABLE 29 GOOGLE: PRODUCT LAUNCHES & ENHANCEMENTS 91
TABLE 30 GOOGLE: DEALS 91
TABLE 31 AWS: BUSINESS OVERVIEW 94
TABLE 32 AWS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 95
TABLE 33 AWS: PRODUCT LAUNCHES & ENHANCEMENTS 95
TABLE 34 AWS: DEALS 96
TABLE 35 AWS: OTHERS 98
TABLE 36 IQVIA: BUSINESS OVERVIEW 99
TABLE 37 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 100
TABLE 38 IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS 101
TABLE 39 IQVIA: DEALS 101
TABLE 40 IQVIA: OTHERS 102
TABLE 41 ORACLE: BUSINESS OVERVIEW 104
TABLE 42 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 105
TABLE 43 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS 106
TABLE 44 ORACLE: DEALS 106
TABLE 45 INOVALON: BUSINESS OVERVIEW 108
TABLE 46 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 108
TABLE 47 INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS 109
TABLE 48 INOVALON: DEALS 109
TABLE 49 INOVALON: OTHERS 110
TABLE 50 DOLBEY SYSTEMS: BUSINESS OVERVIEW 111
TABLE 51 DOLBEY SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 111
TABLE 52 DOLBEY SYSTEMS: PRODUCT LAUNCHES & ENHANCEMENTS 112
TABLE 53 DOLBEY SYSTEMS: DEALS 112
TABLE 54 AVERBIS: BUSINESS OVERVIEW 114
TABLE 55 AVERBIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 114
TABLE 56 AVERBIS: PRODUCT LAUNCHES & ENHANCEMENTS 115
TABLE 57 AVERBIS: DEALS 115
TABLE 58 SAS INSTITUTE: BUSINESS OVERVIEW 116
TABLE 59 SAS INSTITUTE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 116
TABLE 60 SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS 117
TABLE 61 SAS INSTITUTE: DEALS 117
TABLE 62 SAS INSTITUTE: OTHERS 119
TABLE 63 SOLVENTUM: BUSINESS OVERVIEW 120
TABLE 64 SOLVENTUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 121
TABLE 65 SOLVENTUM: DEALS 122
TABLE 66 SOLVENTUM: OTHERS 122

FIGURE 1 SOFTWARE SEGMENT ESTIMATED TO HOLD LARGER MARKET SHARE IN 2025 17
FIGURE 2 NAMED ENTITY RECOGNITION SEGMENT SET TO REGISTER
LARGEST MARKET SHARE IN 2025 18
FIGURE 3 CLINICAL OPERATIONS & DECISION SUPPORT SEGMENT TO HOLD
LARGEST MARKET SHARE IN 2025 18
FIGURE 4 PHARMACEUTICAL & BIOTECH COMPANIES TO LEAD MARKET IN 2025 19
FIGURE 5 ASIA PACIFIC TO REGISTER HIGHEST CAGR BETWEEN 2025 AND 2030 20
FIGURE 6 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 22
FIGURE 7 NLP IN HEALTHCARE & LIFE SCIENCES MARKET EVOLUTION 34
FIGURE 8 FUNCTIONAL ELEMENTS OF NLP IN HEALTHCARE & LIFE SCIENCES SOLUTIONS 35
FIGURE 9 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: SUPPLY CHAIN ANALYSIS 36
FIGURE 10 KEY PLAYERS IN NLP IN HEALTHCARE & LIFE SCIENCES ECOSYSTEM 39
FIGURE 11 NUMBER OF PATENTS GRANTED IN LAST 10 YEARS, 2016-2025 45
FIGURE 12 REGIONAL ANALYSIS OF PATENTS GRANTED, 2016-2025 48
FIGURE 13 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: PORTER'S FIVE FORCES ANALYSIS 51
FIGURE 14 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
TRENDS/DISRUPTIONS IMPACTING BUYERS/CLIENTS 53
FIGURE 15 REVENUE ANALYSIS OF KEY PLAYERS IN NLP IN
HEALTHCARE & LIFE SCIENCES MARKET, 2020-2024 57
FIGURE 16 SHARE OF LEADING COMPANIES IN NLP IN
HEALTHCARE & LIFE SCIENCES MARKET, 2024 58
FIGURE 17 PRODUCT COMPARATIVE ANALYSIS (OFFERING) 60
FIGURE 18 PRODUCT COMPARATIVE ANALYSIS (APPLICATION) 62
FIGURE 19 FINANCIAL METRICS OF KEY VENDORS 64
FIGURE 20 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 64
FIGURE 21 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 66
FIGURE 22 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: COMPANY FOOTPRINT 67
FIGURE 23 NLP IN HEALTHCARE & LIFE SCIENCES MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 72
FIGURE 24 IBM: COMPANY SNAPSHOT 80
FIGURE 25 MICROSOFT: COMPANY SNAPSHOT 84
FIGURE 26 GOOGLE: COMPANY SNAPSHOT 90
FIGURE 27 AWS: COMPANY SNAPSHOT 94
FIGURE 28 IQVIA: COMPANY SNAPSHOT 100
FIGURE 29 ORACLE: COMPANY SNAPSHOT 105
FIGURE 30 SOLVENTUM: COMPANY SNAPSHOT 121
FIGURE 31 NLP IN HEALTHCARE & LIFE SCIENCES MARKET: RESEARCH DESIGN 149

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE